Lyell Immunopharma, Inc. (LYEL)

Lyell Immunopharma, Inc. (LYEL) is a healthcare company (biotechnology) based in the United States. The share price is $13.67, down 6.69% on the day, which values the company at $437.65M. Price as of 18 Nov 2026, 12:56 UTC, from Yahoo Finance.

Key facts

Share price
$13.67−6.69% today
Market value
$437.65M
Funk Score
17/100
200-week average
$28.1251% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Lyell Immunopharma, Inc. in more detail

LYEL trades at -2.3× next year's expected earnings, 29177.0× sales. It sits 51% below its 200-week average of $28.12.

Over the last five fiscal years Lyell Immunopharma, Inc. has compounded revenue -65.9% a year. Its Funk Score is 17 out of 100 (financial strength 3.8, profitability 0.0, growth 1.3, each out of 10).

In its favour: More cash than debt. Worth checking: Altman Z in the distress zone; Weak Piotroski score.

Lyell Immunopharma, Inc. (LYEL): questions and answers

What is Lyell Immunopharma, Inc.'s market cap?

Lyell Immunopharma, Inc. is valued at $437.65M at a share price of $13.67.

Is LYEL above its 200-week moving average?

No. LYEL is 51.4% below its 200-week average of $28.12. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Lyell Immunopharma, Inc. growing?

Over the last five fiscal years Lyell Immunopharma, Inc.'s revenue grew -65.9% a year.

Does LYEL pay a dividend?

Lyell Immunopharma, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Lyell Immunopharma, Inc. (LYEL) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/LYEL

Underlying data: Yahoo Finance; company filings with the SEC.